Literature DB >> 35024810

Histiocytoses converge through common pathways.

Elaine S Jaffe1, John K C Chan2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35024810      PMCID: PMC8759529          DOI: 10.1182/blood.2021014529

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma.

Authors:  Vignesh Shanmugam; Gabriel K Griffin; Eric D Jacobsen; Christopher D M Fletcher; Lynette M Sholl; Jason L Hornick
Journal:  Mod Pathol       Date:  2019-01-09       Impact factor: 7.842

2.  ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female.

Authors:  Gaurav K Gupta; Liqiang Xi; Svetlana D Pack; Jennifer B Jones; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Haematologica       Date:  2019-08-01       Impact factor: 9.941

3.  ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.

Authors:  Kenneth Tou En Chang; Amos Zhi En Tay; Chik Hong Kuick; Huiyi Chen; Elizabeth Algar; Nadine Taubenheim; Janine Campbell; Francoise Mechinaud; Martin Campbell; Leanne Super; Chavit Chantranuwat; S T Yuen; John K C Chan; Chung W Chow
Journal:  Mod Pathol       Date:  2018-12-20       Impact factor: 7.842

4.  ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology.

Authors:  Jumpei Kashima; Masayuki Yoshida; Kenjiro Jimbo; Koji Izutsu; Tetsuo Ushiku; Kan Yonemori; Akihiko Yoshida
Journal:  Am J Surg Pathol       Date:  2021-03-01       Impact factor: 6.394

5.  ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy.

Authors:  John K C Chan; Laurence Lamant; Elizabeth Algar; Georges Delsol; William Y W Tsang; King C Lee; Karin Tiedemann; Chung W Chow
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

Review 6.  Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.

Authors:  Elaine S Jaffe; Nancy Lee Harris; Harald Stein; Peter G Isaacson
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

7.  ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Authors:  Paul G Kemps; Jennifer Picarsic; Benjamin H Durham; Zofia Hélias-Rodzewicz; Laura Hiemcke-Jiwa; Cor van den Bos; Marianne D van de Wetering; Carel J M van Noesel; Jan A M van Laar; Robert M Verdijk; Uta E Flucke; Pancras C W Hogendoorn; F J Sherida H Woei-A-Jin; Raf Sciot; Andreas Beilken; Friedrich Feuerhake; Martin Ebinger; Robert Möhle; Falko Fend; Antje Bornemann; Verena Wiegering; Karen Ernestus; Tina Méry; Olga Gryniewicz-Kwiatkowska; Bozenna Dembowska-Baginska; Dmitry A Evseev; Vsevolod Potapenko; Vadim V Baykov; Stefania Gaspari; Sabrina Rossi; Marco Gessi; Gianpiero Tamburrini; Sébastien Héritier; Jean Donadieu; Jacinthe Bonneau-Lagacherie; Claire Lamaison; Laure Farnault; Sylvie Fraitag; Marie-Laure Jullié; Julien Haroche; Matthew Collin; Jackie Allotey; Majid Madni; Kerry Turner; Susan Picton; Pasquale M Barbaro; Alysa Poulin; Ingrid S Tam; Dina El Demellawy; Brianna Empringham; James A Whitlock; Aditya Raghunathan; Amy A Swanson; Mariko Suchi; Jon M Brandt; Nabeel R Yaseen; Joanna L Weinstein; Irem Eldem; Bryan A Sisk; Vaishnavi Sridhar; Mandy Atkinson; Lucas R Massoth; Jason L Hornick; Sanda Alexandrescu; Kee Kiat Yeo; Kseniya Petrova-Drus; Stephen Z Peeke; Laura S Muñoz-Arcos; Daniel G Leino; David D Grier; Robert Lorsbach; Somak Roy; Ashish R Kumar; Shipra Garg; Nishant Tiwari; Kristian T Schafernak; Michael M Henry; Astrid G S van Halteren; Oussama Abla; Eli L Diamond; Jean-François Emile
Journal:  Blood       Date:  2022-01-13       Impact factor: 22.113

Review 8.  Histiocytosis.

Authors:  Jean-François Emile; Fleur Cohen-Aubart; Matthew Collin; Sylvie Fraitag; Ahmed Idbaih; Omar Abdel-Wahab; Barrett J Rollins; Jean Donadieu; Julien Haroche
Journal:  Lancet       Date:  2021-04-23       Impact factor: 202.731

9.  Efficacy of MEK inhibition in patients with histiocytic neoplasms.

Authors:  Eli L Diamond; Benjamin H Durham; Gary A Ulaner; Esther Drill; Justin Buthorn; Michelle Ki; Lillian Bitner; Hana Cho; Robert J Young; Jasmine H Francis; Raajit Rampal; Mario Lacouture; Lynn A Brody; Neval Ozkaya; Ahmet Dogan; Neal Rosen; Alexia Iasonos; Omar Abdel-Wahab; David M Hyman
Journal:  Nature       Date:  2019-03-13       Impact factor: 49.962

10.  Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups.

Authors:  Caoimhe Egan; Alina Nicolae; Justin Lack; Hye-Jung Chung; Shannon Skarshaug; Thu Anh Pham; Winnifred Navarro; Zied Abdullaev; Nadine S Aguilera; Liqiang Xi; Svetlana Pack; Stefania Pittaluga; Elaine S Jaffe; Mark Raffeld
Journal:  Haematologica       Date:  2019-08-22       Impact factor: 9.941

  10 in total
  1 in total

Review 1.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Authors:  Joseph D Khoury; Eric Solary; Oussama Abla; Yassmine Akkari; Rita Alaggio; Jane F Apperley; Rafael Bejar; Emilio Berti; Lambert Busque; John K C Chan; Weina Chen; Xueyan Chen; Wee-Joo Chng; John K Choi; Isabel Colmenero; Sarah E Coupland; Nicholas C P Cross; Daphne De Jong; M Tarek Elghetany; Emiko Takahashi; Jean-Francois Emile; Judith Ferry; Linda Fogelstrand; Michaela Fontenay; Ulrich Germing; Sumeet Gujral; Torsten Haferlach; Claire Harrison; Jennelle C Hodge; Shimin Hu; Joop H Jansen; Rashmi Kanagal-Shamanna; Hagop M Kantarjian; Christian P Kratz; Xiao-Qiu Li; Megan S Lim; Keith Loeb; Sanam Loghavi; Andrea Marcogliese; Soheil Meshinchi; Phillip Michaels; Kikkeri N Naresh; Yasodha Natkunam; Reza Nejati; German Ott; Eric Padron; Keyur P Patel; Nikhil Patkar; Jennifer Picarsic; Uwe Platzbecker; Irene Roberts; Anna Schuh; William Sewell; Reiner Siebert; Prashant Tembhare; Jeffrey Tyner; Srdan Verstovsek; Wei Wang; Brent Wood; Wenbin Xiao; Cecilia Yeung; Andreas Hochhaus
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.